Pulse Economics will be participating in the Kosi Challenge
Our Blog
ISPOR-AC HTA Harmonisation Workshop
Thank you to ISPOR Australia Chapter for hosting the HTA Harmonisation Workshop yesterday in Sydney. The interactive panel discussions highlighted the lack of harmony in HTA between national and state/territory…
New Medicines Australia member
We are excited to participate in the HTA Review as part of Medicines Australia’s Strategic Agreement with the Federal Government. This is a great opportunity to shape HTA policy and…
HTA Policy and Methods Review – Draft discussion papers
The Australian Government Department of Health and Aged Care has published seven draft discussion papers as part of its HTA Policy and Methods Review. These papers are now available for…
Medicines Australia Horizon Scanning Forum
Our Medicines Australia Horizon Scanning Forum presentation highlighted the journey of AI-enabled IVD from Parkinson’s prognosis to broader neurological applications. As advancements continue, we see these tools embracing conditions like…
Australian Comprehensive Cancer Network (ACCN) Launch
On behalf of health economists, thank you to Cancer Australia for launching the Australian Comprehensive Cancer Network (ACCN)! At yesterday’s Innovation Showcase, research groups from VIC, QLD, ACT, SA and Cancer Institute NSW demonstrated…
HTA careers in the MedTech Sector
I am thrilled to have had the opportunity to speak at the ARCS Australia Conference 2024! It was an honour to share my insights on entering a career in Market…
Harnessing Real World Data and Evidence
What’s the Difference Between Real World Data and Real World Evidence? While often used interchangeably, there is clear distinction between the terms Real World Data (RWD) and Real World Evidence…
Unlocking Consumer Insights in Health Technology Assessment
Ever asked for feedback? The results can often be quite surprising. We might find ourselves pondering questions like, “Why did they focus on that particular point?” or “Why did they…
Finding Australian Real-World Data for Reimbursement Submissions: A Guide
Introduction Navigating the pathway to reimbursement can often feel like an uphill battle, and you’re not alone in this struggle. Market Access professionals frequently encounter challenges such as: Difficulty securing…
Positioning Australia’s life sciences industry for global success
Australia is a leader in niche life science segments with strong global markets, including plasma therapies, hearing implants, and sleep apnoea devices. Yet, despite billions in public and private investment,…
The digital health market access challenge in Australia
What we’re seeing We’ve been working with some remarkable Australian digital health companies lately. These are teams with genuinely impressive clinical evidence and technology that could meaningfully improve patient care.…